Hughes Owen insider trades
Hughes Owen has filed 25 Form 4s with the SEC that we hold, for XOMA Royalty Corp (XOMA) (Chief Executive Officer, Director), C4 Therapeutics, Inc. (CCCC) (Director), ImageneBio, Inc. (IKNA) (Director) and PRDS (Director), among 7 companies in all. Across all of them we count 7 purchases worth $2.6M and 3 sales worth $2.4M reported on Form 4. In the last 12 months: 1 purchase ($2.5M) and 0 sales ($0). The largest single trade was a purchase of 100,000 shares of XOMA Royalty Corp worth $2.5M, dated 2025-12-04. The first filing on our record is dated 2021-09-14 and the latest 2026-07-14.
XOMA Royalty Corp (XOMA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-05-23 | P, purchase reported on Form 4 | 768 | $18.0K | 2023-05-25 |
| 2023-05-23 | P, purchase reported on Form 4 | 200 | $4.7K | 2023-05-25 |
| 2023-05-24 | P, purchase reported on Form 4 | 1,032 | $24.6K | 2023-05-25 |
| 2023-09-25 | P, purchase reported on Form 4 | 1 | $15 | 2023-09-27 |
| 2023-09-26 | P, purchase reported on Form 4 | 2,499 | $36.1K | 2023-09-27 |
| 2023-10-02 | P, purchase reported on Form 4 | 1,000 | $13.8K | 2023-10-04 |
| 2024-11-13 | S, sale reported on Form 4 | 21,881 | $655.3K | 2024-11-13 |
| 2025-05-20 | S, sale reported on Form 4 | 25,637 | $650.7K | 2025-05-21 |
| 2025-12-04 | P, purchase reported on Form 4 | 100,000 | $2.5M | 2025-12-08 |
C4 Therapeutics, Inc. (CCCC)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
ImageneBio, Inc. (IKNA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
PRDS
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
RDUS
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Anaptysbio, INC (ANAB)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
TBIO
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-09-14 | S, sale reported on Form 4 | 29,860 | $1.1M | 2021-09-14 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1575933) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms